Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-25-001835
Filing Date
2025-05-16
Accepted
2025-05-15 17:41:47
Documents
218
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2533151.htm   iXBRL 20-F 7125808
2 EXHIBIT 4.13 exhibit_4-13.htm EX-4.13 25466
3 EXHIBIT 4.14 exhibit_4-14.htm EX-4.14 25946
4 EXHIBIT 4.23 exhibit_4-23.htm EX-4.23 26501
5 EXHIBIT 4.24 exhibit_4-24.htm EX-4.24 179898
6 EXHIBIT 4.25 exhibit_4-25.htm EX-4.25 162879
7 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 15080
8 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 14014
9 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4934
10 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5086
11 EXHIBIT 15.2 exhibit_15-2.htm EX-15.2 8586
12 EXHIBIT 97.1 exhibit_97-1.htm EX-97.1 42664
18 GRAPHIC image6.jpg GRAPHIC 65331
19 GRAPHIC image00005.jpg GRAPHIC 7614
20 GRAPHIC image00004.jpg GRAPHIC 7544
21 GRAPHIC image2.jpg GRAPHIC 69882
22 GRAPHIC image00007.jpg GRAPHIC 48618
23 GRAPHIC image00008.jpg GRAPHIC 42916
24 GRAPHIC image00009.jpg GRAPHIC 48441
25 GRAPHIC image1.jpg GRAPHIC 70197
  Complete submission text file 0001178913-25-001835.txt   35556991

Data Files

Seq Description Document Type Size
13 XBRL PRESENTATION FILE trib-20241231_pre.xml EX-101.PRE 1175369
14 XBRL LABEL FILE trib-20241231_lab.xml EX-101.LAB 2303896
15 XBRL DEFINITION FILE trib-20241231_def.xml EX-101.DEF 824780
16 XBRL CALCULATION FILE trib-20241231_cal.xml EX-101.CAL 102099
17 XBRL SCHEMA FILE trib-20241231.xsd EX-101.SCH 298665
221 EXTRACTED XBRL INSTANCE DOCUMENT zk2533151_htm.xml XML 9055214
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 25956147
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)